Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases

Sriram Venneti, John L. Robinson, Subhojit Roy, Matthew T. White, Jennifer Baccon, Sharon X. Xie, John Q. Trojanowski

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Risks associated with brain biopsy limit availability of tissues and the role of brain biopsy in diagnosing neurodegeneration is unclear. We developed a simulated brain biopsy paradigm to comprehensively evaluate potential accuracy of detecting neurodegeneration in biopsies. Postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including Alzheimer's disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP43 (FTLD-TDP), multiple system atrophy (MSA), Pick's disease (PiD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were evaluated using H&E and immunostains. Brain biopsy was simulated in a blinded manner by masking each slide with opaque tape except for an area measuring 10 mm in diameter. Diagnoses obtained from frontal cortex only or all 4-brain regions were then compared with autopsy diagnoses. Diagnostic sensitivity in frontal cortex was highest in FTLD-TDP (88%), AD (80%) and LBD (79%); intermediate for MSA (71%), CBD (66%) and PiD (66%) and lowest for PSP (0%) (average 64%). Specificity was 43%. Sensitivities were enhanced with all 4-brain regions: FTLD-TDP (100%), AD (80%), LBD (100%), MSA (100%), CBD (83%), PiD (100%) and PSP (88%) (average 92%). Specificity was 71%. Simulated brain biopsy addressed limitations of standard brain biopsies such as tissue availability and lack of autopsy confirmation of diagnoses. These data could inform efforts to establish criteria for biopsy diagnosis of neurodegenerative disorders to guide care of individuals who undergo biopsy for enigmatic causes of cognitive impairment or when evidence of an underlying neurodegenerative disease may influence future therapy.

Original languageEnglish (US)
Pages (from-to)737-745
Number of pages9
JournalActa Neuropathologica
Volume122
Issue number6
DOIs
StatePublished - Dec 1 2011

Fingerprint

Autopsy
Biopsy
Brain
Pick Disease of the Brain
Frontotemporal Lobar Degeneration
Progressive Supranuclear Palsy
Multiple System Atrophy
Lewy Body Disease
Frontal Lobe
Alzheimer Disease
Neurodegenerative Diseases
Parietal Lobe
Temporal Lobe
Basal Ganglia

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Venneti, S., Robinson, J. L., Roy, S., White, M. T., Baccon, J., Xie, S. X., & Trojanowski, J. Q. (2011). Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. Acta Neuropathologica, 122(6), 737-745. https://doi.org/10.1007/s00401-011-0880-5
Venneti, Sriram ; Robinson, John L. ; Roy, Subhojit ; White, Matthew T. ; Baccon, Jennifer ; Xie, Sharon X. ; Trojanowski, John Q. / Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. In: Acta Neuropathologica. 2011 ; Vol. 122, No. 6. pp. 737-745.
@article{a3982dc6ca1d4e28a5371482f0ea80e8,
title = "Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases",
abstract = "Risks associated with brain biopsy limit availability of tissues and the role of brain biopsy in diagnosing neurodegeneration is unclear. We developed a simulated brain biopsy paradigm to comprehensively evaluate potential accuracy of detecting neurodegeneration in biopsies. Postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including Alzheimer's disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP43 (FTLD-TDP), multiple system atrophy (MSA), Pick's disease (PiD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were evaluated using H&E and immunostains. Brain biopsy was simulated in a blinded manner by masking each slide with opaque tape except for an area measuring 10 mm in diameter. Diagnoses obtained from frontal cortex only or all 4-brain regions were then compared with autopsy diagnoses. Diagnostic sensitivity in frontal cortex was highest in FTLD-TDP (88{\%}), AD (80{\%}) and LBD (79{\%}); intermediate for MSA (71{\%}), CBD (66{\%}) and PiD (66{\%}) and lowest for PSP (0{\%}) (average 64{\%}). Specificity was 43{\%}. Sensitivities were enhanced with all 4-brain regions: FTLD-TDP (100{\%}), AD (80{\%}), LBD (100{\%}), MSA (100{\%}), CBD (83{\%}), PiD (100{\%}) and PSP (88{\%}) (average 92{\%}). Specificity was 71{\%}. Simulated brain biopsy addressed limitations of standard brain biopsies such as tissue availability and lack of autopsy confirmation of diagnoses. These data could inform efforts to establish criteria for biopsy diagnosis of neurodegenerative disorders to guide care of individuals who undergo biopsy for enigmatic causes of cognitive impairment or when evidence of an underlying neurodegenerative disease may influence future therapy.",
author = "Sriram Venneti and Robinson, {John L.} and Subhojit Roy and White, {Matthew T.} and Jennifer Baccon and Xie, {Sharon X.} and Trojanowski, {John Q.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1007/s00401-011-0880-5",
language = "English (US)",
volume = "122",
pages = "737--745",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

Venneti, S, Robinson, JL, Roy, S, White, MT, Baccon, J, Xie, SX & Trojanowski, JQ 2011, 'Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases', Acta Neuropathologica, vol. 122, no. 6, pp. 737-745. https://doi.org/10.1007/s00401-011-0880-5

Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. / Venneti, Sriram; Robinson, John L.; Roy, Subhojit; White, Matthew T.; Baccon, Jennifer; Xie, Sharon X.; Trojanowski, John Q.

In: Acta Neuropathologica, Vol. 122, No. 6, 01.12.2011, p. 737-745.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases

AU - Venneti, Sriram

AU - Robinson, John L.

AU - Roy, Subhojit

AU - White, Matthew T.

AU - Baccon, Jennifer

AU - Xie, Sharon X.

AU - Trojanowski, John Q.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Risks associated with brain biopsy limit availability of tissues and the role of brain biopsy in diagnosing neurodegeneration is unclear. We developed a simulated brain biopsy paradigm to comprehensively evaluate potential accuracy of detecting neurodegeneration in biopsies. Postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including Alzheimer's disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP43 (FTLD-TDP), multiple system atrophy (MSA), Pick's disease (PiD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were evaluated using H&E and immunostains. Brain biopsy was simulated in a blinded manner by masking each slide with opaque tape except for an area measuring 10 mm in diameter. Diagnoses obtained from frontal cortex only or all 4-brain regions were then compared with autopsy diagnoses. Diagnostic sensitivity in frontal cortex was highest in FTLD-TDP (88%), AD (80%) and LBD (79%); intermediate for MSA (71%), CBD (66%) and PiD (66%) and lowest for PSP (0%) (average 64%). Specificity was 43%. Sensitivities were enhanced with all 4-brain regions: FTLD-TDP (100%), AD (80%), LBD (100%), MSA (100%), CBD (83%), PiD (100%) and PSP (88%) (average 92%). Specificity was 71%. Simulated brain biopsy addressed limitations of standard brain biopsies such as tissue availability and lack of autopsy confirmation of diagnoses. These data could inform efforts to establish criteria for biopsy diagnosis of neurodegenerative disorders to guide care of individuals who undergo biopsy for enigmatic causes of cognitive impairment or when evidence of an underlying neurodegenerative disease may influence future therapy.

AB - Risks associated with brain biopsy limit availability of tissues and the role of brain biopsy in diagnosing neurodegeneration is unclear. We developed a simulated brain biopsy paradigm to comprehensively evaluate potential accuracy of detecting neurodegeneration in biopsies. Postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including Alzheimer's disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP43 (FTLD-TDP), multiple system atrophy (MSA), Pick's disease (PiD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were evaluated using H&E and immunostains. Brain biopsy was simulated in a blinded manner by masking each slide with opaque tape except for an area measuring 10 mm in diameter. Diagnoses obtained from frontal cortex only or all 4-brain regions were then compared with autopsy diagnoses. Diagnostic sensitivity in frontal cortex was highest in FTLD-TDP (88%), AD (80%) and LBD (79%); intermediate for MSA (71%), CBD (66%) and PiD (66%) and lowest for PSP (0%) (average 64%). Specificity was 43%. Sensitivities were enhanced with all 4-brain regions: FTLD-TDP (100%), AD (80%), LBD (100%), MSA (100%), CBD (83%), PiD (100%) and PSP (88%) (average 92%). Specificity was 71%. Simulated brain biopsy addressed limitations of standard brain biopsies such as tissue availability and lack of autopsy confirmation of diagnoses. These data could inform efforts to establish criteria for biopsy diagnosis of neurodegenerative disorders to guide care of individuals who undergo biopsy for enigmatic causes of cognitive impairment or when evidence of an underlying neurodegenerative disease may influence future therapy.

UR - http://www.scopus.com/inward/record.url?scp=82355191790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82355191790&partnerID=8YFLogxK

U2 - 10.1007/s00401-011-0880-5

DO - 10.1007/s00401-011-0880-5

M3 - Article

C2 - 21959586

AN - SCOPUS:82355191790

VL - 122

SP - 737

EP - 745

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -